565results about How to "Prevent skin" patented technology

A method and apparatus are provided for targeting lipid-rich tissue to effect a desired, the method/apparatus involving irradiating the lipid-rich tissue with energy at a wavelength preferentially absorbed by lipid cells, such wavelength being preferably in a band between 880 nm and 935 nm, 1150 nm and 1230 nm, 1690 nm to 1780 nm, or 2250 nm to 2450 nm with a fluence and duration sufficient to achieve a desired treatment. For preferred embodiments, the irradiation wavelength is between 900–930 nm, 1190–1220 nm, 1700–1730 nm, or 2280–2350 nm. The method and apparatus may for example be used to target one or more sebaceous glands for the treatment of acne or hair removal, to target subcutaneous fat for removal thereof or for targeting fat on anatomical elements for various purposes.

Methods and compositions are disclosed for the preparation of free radical scavenging polymers and polymer films functionalized with antioxidants. Enzymatic and chemical tailoring of monomers with antioxidants followed by enzymatic polymerization is described. These antioxidant functionalized polymers can increase shelf life and quality of food products, as well as, increase effectiveness of pharmaceutical agents when used as packaging or as coatings on packaging for oxygen sensitive materials. The novel enzymatic covalent coupling of antioxidants to a polymer enhances the free radical scavenging ability of packaging while also inhibiting the escape of the antioxidants, and thus limiting exposure and/or absorption by an individual. In addition to its use in food or pharmaceutical packaging, methods are disclosed for using the antioxidant coupled polymers in a variety of applications including as coatings on the inside of medical devices, such as stents and catheters, which would substantially reduce free radical damage and/or oxygen depletion during medical procedures. Furthermore, through the coupling of antioxidants to biodegradable polymers, controlled delivery and sustained release of an antioxidant to a subject is possible.

An antibacterial/anti-inflammatory composition and method wherein the pairing of synergistic active ingredients with a natural enhancer for a more efficacious formulation for topical application treatments is used. Active ingredients hydrocortisone 1% and benzoyl peroxide 10% are paired with Emu Oil to increase the percentage of absorption of the ingredients through the skin. The preferred method of use of the composition is via a dual-pharmaceutical delivery syringe that isolates components (1) having a barrel (9), a piston (8) and a commonly shared split nozzle (5). The barrel (9) has two syringe compartments (2) and (14) attached to one another and connected to the split nozzle (5). The piston (8) has two plungers (6) connected via a bridge (12). A user applies force to the piston (8), dispersing the substances in the syringe compartments (2) and (14) through the respective sides of the split nozzle (5) onto the user's skin. The user then massages the substances into the skin for “hands-on healing.”

A method and apparatus for preventing abrasion on an infant's nose and adjacent areas when used in conjunction with respiratory administration devices.

A method of forming a structural airframe component for an aircraft and an airframe structural component The method includes placing at least two components (1,2) in abutting relationship with each other and joining them together by friction stir butt welding (3), and the structural airframe component comprises a component manufactured according to the method of the invention.

The present invention has an object to provide a means for durably exerting an action of enhancing collagen-production, and the object is attained by providing a collagen-production enhancer which contains, as an effective ingredient, α,α-trehalose and/or a saccharide derivative thereof, and by a composition incorporated with the collagen-production enhancer to be used for such purpose.

The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α₁-adrenergic receptor (α₁-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.

A method for the cosmetic treatment of skin, especially for epilation, skin remodeling and treatment of acne whereby an appropriate cosmetically effective wavelength of light is produced using a fluorescent material pumped with ultraviolet light from an ultraviolet light source.

An anti-aging pillow provides, in the exemplary embodiment, a top surface providing a substantially central supine section flanked by an upwardly sloping left side section and a substantially symmetrical right side section, the left and right side sections elevated relatively higher than the supine section. The supine section is configured for accommodating a user when lying in a supine position, while each of the left and right side sections is configured for accommodating the user when lying in a respective side position. This configuration enables the pillow to both substantially prevent the user from unintentionally changing sleep positions as well as substantially assist in physically directing the user in selectively transitioning between each of the supine position and left and right side positions as desired, while substantially maintaining the user's head, neck, shoulders, and back in neutral alignment and substantially preventing facial contact with the pillow or underlying sleeping surface.

A wearable sensor device, system, and methods for electronically monitoring safe ultraviolet and infrared radiations and beneficial visible light exposure based on sensor data and clinical information data relevant to estimate a personalized radiation pattern for disease prevention, a personalized radiation pattern for an evolution in disease activity or skin aging from radiation exposure of the user of the wearable sensor device and other users of the wearable sensor device. The wearable sensor device includes one or more UV sensors, an ambient light sensor, one IR sensor, and the wearable sensor device is in communication with remote computing devices to communicate sensor data and to calculate, send, and receive recommendations regarding beneficial radiation exposure and safe UV and IR exposure at the wearable sensor device, or remote computing devices paired with or connected to the wearable sensor device.

Equol (7-hydroxy-3(4′hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5α-dihydrotestosterone (DHT) in vitro and in vivo. Equol can bind circulating free DHT and sequester it from the androgen receptor, thus altering growth and physiological hormone responses that are regulated by androgens. These data suggest a novel model to explain equol's biological properties. The significance of equol's ability to specifically bind and sequester DHT from the androgen receptor have important ramifications in health and disease and may indicate a broad and important usage for equol in the treatment and prevention of androgen-mediated pathologies of skin and hair. Thus, equol can specifically bind DHT and prevent DHT's biological actions in physiological and pathophysiological processes affecting skin and hair.

Provided is a nutrient composition for promoting collagen production, which contains vitamin C, an iron preparation, and collagen as active ingredients, promotes collagen production in a living body such as skin or bone, prevents or treats skin aging or bone and joint diseases, and is an iron preparation-containing composition having stability imparted thereto. Also provided are a food or beverage, a feed, and a medicine each containing the nutrient composition incorporated therein.

The present invention implements a strategy that combines an enzyme inhibition assay with a chemical dereplication process to identify active plant extracts and the particular compounds—diarylalkanes and/or diarylalkanols within those extracts that specifically inhibit binuclear enzyme function. Included in the present invention are compositions of matter comprised of one or more of diarylalkanes and/or diarylalkanols, which inhibit the activity of binuclear enzymes, particularly tyrosinase and which prevent melanin overproduction. The present invention also provides a method for inhibiting the activity of a binuclear enzyme, particularly tyrosinase and a method for preventing and treating diseases and conditions related to binuclear enzyme function. The present invention further includes a method for preventing and treating melanin overproduction and diseases and conditions of the skin related thereto. The method for preventing and treating diseases and conditions related to binuclear enzyme function and melanin overproduction is comprised of administering to a host in need thereof an effective amount of a composition comprising one or more diarylalkanes and/or diarylalkanols synthesized and/or isolated from one or more plants together with a pharmaceutically acceptable carrier.

The present invention relates to methods and compositions comprising naphthoquinones such as 2,3-dimethylnaphthalene-1,4-dione, for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible and/or tactile discontinuities of the skin resulting from skin pigmentation or skin aging are also disclosed.

This application relates to a stable pharmaceutical composition and methods for the cleaning of skin to facilitate the prevention, treatment, and management of skin conditions, such as seborrheic dermatitis, psoriasis, folliculitis, rosacea, perioral dermatitis, acne, impetigo and other inflammatory skin conditions, and the like, including a sufficient amount of an acidic component of a hydroxyacid or tannic acid, or a pharmaceutically acceptable salt thereof, to exfoliate a portion of the skin, a sufficient amount of stabilized hydrogen peroxide to facilitate cleansing of the skin without substantial irritation thereof, and an antimicrobial agent including at least one of an antibacterial agent, antimicrobial agent, antiviral agent, anthelmintic, or a combination thereof, in an amount sufficient to inhibit or reduce microorganisms on the skin.

Topical ointment for preventing and treating diaper rash are disclosed. The topical ointments comprise an emollient, a structurant, a rheology enhancer, and other optional components. In one preferred embodiment, the topical ointment comprises a particulate material such as zinc oxide as an optional component.

The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.

The present invention has objects to provide an extract powder of indigo plant, which has a relatively low hygroscopicity, satisfactory fluidability, and improved storage stability; a process thereof; and a composition incorporated with the extract powder. The objects are solved by a process for producing an extract powder of indigo plant, which comprises incorporating a partial starch hydrolyzate with a dextrose equivalent of 10.2 or lower into one part by weight, on a dry solid basis, of an indigo plant extract contained in a liquid extract of indigo plant in an amount of not lower than 0.25 part by weight but not higher than 5 parts by weight, on a dry solid basis, and drying the resulting mixture; an extract powder of indigo plant prepared thereby; and a composition incorporated with the extract powder.

The present invention relates to a method for stimulating collagen synthesis and/or KGF expression, and more particularly, to a method for stimulating collagen synthesis and/or KGF expression using the AIMP1 or its fragment. The AIMP1 or its fragment can be effectively used for the stimulation of collagen synthesis and/or KGF expression in a subject in need thereof, the treatment of skin aging in the subject, the treatment of the flaccid and/or wrinkled skin in the subject, the promoting the smoothing and/or firming of the skin in the subject, the treatment of adverse cutaneous effects of menopause in the subject, and the treatment of adverse effects of menopause on the collagen.

A microneedle roller includes a plurality of discs, each of which comprises a first side surface, a second side surface and a center hole. The first side surface comprises a plurality of radial grooves, and the discs are stacked on one another in a way that the first side surface of one disc contacts the second side surface of the adjacent disc. The microneedle roller further includes a plurality of microneedles that are received in the radial grooves of the disc, and each of which has a pointed end. The pointed end protrudes beyond the outer circumference of the disc. The microneedle comprises an elongated cylindrical needle shank, a first sloped portion that starts from the pointed end, and a second sloped portion that is provided between the first sloped portion and the second sloped portion. The angle of the first sloped portion is greater.

A double diaper package includes adhesively attached, similarly sized inner and outer diapers. Each of the diapers has a liquid permeable skin contacting net and a liquid impermeable polymeric back sheet edge bonded to each other so as to surround and encase a super-absorber in a fibrous matrix. The inner diaper has an adhesive coated edge flap of the liquid impermeable sheet extending from the edge bond. This edge flap secures the outer diaper to the inner diaper, forming a double diaper package that is attached to the baby using waist-securing tabs connected to the inner diaper. When soiled, the inner diaper is pulled away by releasing the waist-securing tabs and the adhesive edge flap attachment. The fresh, clean, outer diaper is attached using the waist-securing tabs of the outer diaper. The inner soiled diaper is then discarded.

The present invention provides peptides and supported peptides for treating various diseases and conditions. In particularly preferred embodiments, the present invention provides compositions and methods for personal care. In some embodiments, the present invention provides compositions for use in skin and/or hair care, as well as cosmetic compositions. In alternative particularly preferred embodiments, the present invention provides peptides and supported peptides for treating diseases of the skin, such as rosacea. In some particularly preferred embodiments, the supported peptides of the present invention are anti-VEGF peptides. In alternative particularly preferred embodiments, the anti-VEGF peptides are expressed on a scaffold protein. In some most preferred embodiments, the scaffold protein comprises BBI.